ESC Professional Premium Access

Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial

Congress Presentation

About the speaker

Doctor Emrush Rexhaj

Bern University Hospital, Inselspital, Bern (Switzerland)
1 presentation
0 follower

5 more presentations in this session

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention 12 months after acute myocardial infarction. Results of the prospective GULLIVE-R study.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)


Infarct size, inflammatory burden and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.

Speaker: Doctor A. Sansonetti (Bologna, IT)


The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Speaker: Ms E. Woelders (Nijmegen, NL)


Positive predictive value of the crusade score for bleeding events in patients with acute coronary syndromes on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel

Speaker: Doctor J. Monteiro (Vila Real, PT)


To pretreat or not no pretreat with dual antiplatelet therapy in non-ST elevation acute coronary syndrome patients: that is the question.

Speaker: Doctor D. Abella Vallina (Burgos, ES)


Access the full session

Treatment of coronary artery disease

Speakers: Doctor E. Rexhaj, Professor U. Zeymer, Doctor A. Sansonetti, Ms E. Woelders, Doctor J. Monteiro...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb